Teladoc Health (TDOC)
(Delayed Data from NYSE)
$8.75 USD
-0.43 (-4.68%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $8.77 +0.02 (0.23%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
Company Summary
Headquartered in Purchase, NY, Teladoc Health, Inc. provides virtual access to high-quality care and expertise with a portfolio of services and solutions, covering several medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company combines the latest in data and analytics with an award-winning user experience through a highly flexible technology platform. It was first incorporated in 2002.
The company provides access to healthcare through its portfolio of five consumer brands 24 hours a day, seven days a ...
Company Summary
Headquartered in Purchase, NY, Teladoc Health, Inc. provides virtual access to high-quality care and expertise with a portfolio of services and solutions, covering several medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company combines the latest in data and analytics with an award-winning user experience through a highly flexible technology platform. It was first incorporated in 2002.
The company provides access to healthcare through its portfolio of five consumer brands 24 hours a day, seven days a week and 365 days a year. Its solutions are delivered with an approximate median response time of less than ten minutes in the United States for general medical inquiries from the time a member requests a general medical telehealth visit to the time they consult with a Teladoc Health network provider.
It currently provides virtual healthcare services on a business-to-business (B2B) basis to more than 12,000 total Clients. With its massive network and integrated technology platform, Teladoc is well-poised to capitalize on the growing demand for virtual healthcare services. The company witnessed total visits of around 18.4 million in 2023.
Teladoc Health has a global footprint spanning clients, medical operations and members, and has offices spread across North America, South America, Europe, Asia-Pacific and the Middle East. TDOC generated total revenues of $2.6 billion for 2023. Its reportable segments include:
Teladoc Health Integrated Care - (56.4% of total revenues in 2023) The segment encompasses a portfolio of global virtual medical services consisting of general medical, expert medical services, specialty medical, chronic condition management and mental health. The unit is also entrusted with extending technologies and enterprise telehealth solutions for hospitals and health systems.
BetterHelp – (43.6%) The BetterHelp segment consists of a direct-to-consumer mental health platform, which is leveraged by a network of more than 30,000 licensed clinicians to deliver online counseling and therapy services via web, mobile app, phone and text-based consultations.
Other – It contains revenues and expenses that cannot be linked with ongoing segment operations.
General Information
Teladoc Health, Inc
2 MANHATTANVILLE ROAD SUITE 203
PURCHASE, NY 10577
Phone: 203-635-2002
Fax: NA
Web: http://www.teladochealth.com
Email: ir@teladochealth.com
Industry | Medical Services |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 6/30/2024 |
Exp Earnings Date | 10/22/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | -0.29 |
Current Year EPS Consensus Estimate | -5.36 |
Estimated Long-Term EPS Growth Rate | NA |
Exp Earnings Date | 10/22/2024 |
Price and Volume Information
Zacks Rank | |
Yesterday's Close | 9.18 |
52 Week High | 22.54 |
52 Week Low | 6.76 |
Beta | 0.90 |
20 Day Moving Average | 5,665,665.00 |
Target Price Consensus | 10.89 |
4 Week | 17.92 |
12 Week | -10.53 |
YTD | -59.40 |
4 Week | 16.52 |
12 Week | -14.33 |
YTD | -64.44 |
Shares Outstanding (millions) | 171.22 |
Market Capitalization (millions) | 1,498.16 |
Short Ratio | NA |
Last Split Date | NA |
Dividend Yield | 0.00% |
Annual Dividend | $0.00 |
Payout Ratio | NA |
Change in Payout Ratio | NA |
Last Dividend Payout / Amount | NA / $0.00 |
Fundamental Ratios
P/E (F1) | NA |
Trailing 12 Months | NA |
PEG Ratio | NA |
vs. Previous Year | 30.00% |
vs. Previous Quarter | 42.86% |
vs. Previous Year | -1.53% |
vs. Previous Quarter | -0.57% |
Price/Book | 1.00 |
Price/Cash Flow | 10.78 |
Price / Sales | 0.57 |
6/30/24 | -10.25 |
3/31/24 | -10.13 |
12/31/23 | -9.22 |
6/30/24 | -5.20 |
3/31/24 | -5.37 |
12/31/23 | -4.89 |
6/30/24 | 1.66 |
3/31/24 | 3.82 |
12/31/23 | 3.54 |
6/30/24 | 1.62 |
3/31/24 | 3.74 |
12/31/23 | 3.47 |
6/30/24 | -8.26 |
3/31/24 | -8.90 |
12/31/23 | -8.15 |
6/30/24 | -38.54 |
3/31/24 | -8.90 |
12/31/23 | -8.47 |
6/30/24 | -38.24 |
3/31/24 | -8.79 |
12/31/23 | -8.44 |
6/30/24 | 8.77 |
3/31/24 | 13.50 |
12/31/23 | 14.05 |
6/30/24 | 22.99 |
3/31/24 | 23.21 |
12/31/23 | 20.92 |
6/30/24 | 0.66 |
3/31/24 | 0.67 |
12/31/23 | 0.66 |
6/30/24 | 39.72 |
3/31/24 | 40.21 |
12/31/23 | 39.81 |